Skip to content
Storytelling Co – Lifestyle
Author:
OXB
OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme
July 16, 2026
OXB Capital Markets Event
June 2, 2026
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
May 8, 2026
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
April 13, 2026
OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards
March 27, 2026
OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms
March 18, 2026